Jaime Saap Nuno. MSN- FNP-RN

License and Certification:

Nurse Practitioner License #APRNl 1009832
Registered Nurse License #RN9501722
Medical Doctor, Specialist in Internal Medicine (Cuba)
Registered Medical Assistant
Registered Phlebotomist Technician
Registered Electrocardiography Technician

Education and Training:

03/26/2024
NIDA CLINICAL TRIALS NETWORK
Good Clinical Practices Exp: 03/26/2027

Introduction
Institutional Review Boards
Informed Consent
Confidentiality & Privacy
Participant Safety & Adverse Events
Quality Assurance
The Research Protocol
Documentation & Record Keeping
Research Misconduct
Roles & Responsibilities
Recruitment & Retention
Investigational New Drugs

03/25/2024
Transporting Dangerous Goods Training
Mayo Clinic Laboratories Exp: 25Mar2026

03/25/2024
Handling/offering for transportation of Dangerous Goods
Mayo Clinic Laboratories (IATA) Exp:25Mar2026

2020
Master’s Degree of Science in Nursing
Miami Regional University, Miami, Fl

2018
Associates of Science in Nursing
International Institute for Healthcare Professionals
Boca Raton, Fl

1992
Medical Doctor, Specialist Internal Medicine
Instituto Superior de Ciencias Médicas de la Habana, Cuba

1987
Medical Doctor

Professional Experience:

02/2024- Present
Sub-investigator
CLA Research Center, Naples, Fl

2019- Present
Registered Nurse
Opus Care of south Florida, Miami, FL

2016-2019
Quality Assurance Specialist
Ariza Quality Medical Services INC,
Miami, Fl

1987-2015
Medical Doctor
Hospital General de Guantanamo, Guantanamo Cuba

Clinical Trials and Research

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of XXXX in Adults with Focal Seizures (07/2025-ONGOING)
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of XXXX in Adult Patients with Focal Onset or Primary Generalized Tonic-Clonic
Seizures(05/2025-Ongoing)
An Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive XXX in Subjects with Inadequately Controlled Symptoms of Schizophrenia.
1-01/2026 -ongoing –A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment with Brenipatide in Delaying Time to Relapse
Compared with Placebo in Adult Participants with Bipolar Disorder (RENEW-Bipolar-1)
2- 02-2026-ongoing A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the
Efficacy and Safety of Adjunctive Treatment with Brenipatide in Delaying Time to Relapse
Compared with Placebo in Adult Participants with Major Depressive Disorder (RENEWMDD-1)
3-04-2026-ongoing-A Phase 2 Multicenter, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment with Brenipatide in Adult Participants with Schizophrenia (RENEWScz-1)
4-04-2026-ongoing-A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the
Efficacy and Safety of Adjunctive Treatment with Brenipatide in Delaying Time to Relapse
Compared with Placebo in Adult Participants with Major Depressive Disorder (RENEWMDD-2)

Languages:

Fluent English, Portuguese and Spanish